Viral Antigens Market | Size, Share, and Forecast [2021-2031]
The Viral Antigens Market size was estimated to be US$ 156.13 million in 2023 and is expected to reach US$ 366.09 million by 2031; it is estimated to record a CAGR of 11.2% till 2031. Development of plant-made vaccine antigens and biopharmaceuticals are likely to remain key Viral Antigens Market trends.
Viral Antigens Market Analysis
The rising prevalence of viral infections worldwide, including, HIV, influenza, hepatitis, and respiratory viruses like COVID-19, drives the demand for viral antigens which are used in diagnostic studies. Advancements in molecular biology, government initiatives for vaccine development against emerging viruses, increasing R&D activities for diagnostic technique development and vaccine development, and increasing investment in viral antigen research is fueling the growth of the viral antigen market.
Viral Antigens Market Overview
A virus can infect all types of life forms, from plants and animals to archaea and bacteria. A virus antigen is a poison or toxic substance administered by a virus that induces an immune reaction in its host. A viral protein is an antigen identified by the viral genome that can be recognized through a particular immunological response. A viral antigen is determined by IFA in neutrophils and platelets from bone marrow or blood or in serum, saliva, tears, or plasma by ELISA. Nucleic amplification tests can also be used to determine the stage of infection. The best outcomes are obtained when antigens are measured through blood tests or serum.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Viral Antigens Market: Strategic Insights
Market Size Value in US$ 101.41 Million in 2019 Market Size Value by US$ 236.80 Million by 2027 Growth rate CAGR of 11.0% from 2020-2027 Forecast Period 2020-2027 Base Year 2020
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Viral Antigens Market: Strategic Insights
| Market Size Value in | US$ 101.41 Million in 2019 |
| Market Size Value by | US$ 236.80 Million by 2027 |
| Growth rate | CAGR of 11.0% from 2020-2027 |
| Forecast Period | 2020-2027 |
| Base Year | 2020 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Viral Antigens Market Drivers and Opportunities
Increased Awareness of Viral Antigens in Vaccine Development
Viral antigens play an important role in vaccine development, as they are the component detected by immune system for protection. For instance, when a person is infected with a virus, their immune system recognises specific viral antigens as foreign and mounts a response to eliminate the virus. Viral antigens in vaccines exposes the immune system to these specific anitgens in a controlled manner and thus helping the person to develop immune response against the virus. The development and use of vaccines has greatly reduced the number of illnesses and diseases over the years. The introduction of a variety of new types of vaccines has been made possible through the manipulation of DNA, RNA, proteins and sugars, increased knowledge of immune response, and a major leap in genetic engineering. Development of attenuated mutants, expression of possible antigens in live vectors, and purification and direct synthesis of antigens in new systems have significantly enhanced the vaccine technology. Thus, increased acceptance of viral antigens in vaccine development is expected to drive the market during the forecast period.
Growing Awareness about Preventive Healthcare – An Opportunity of Viral Antigens Market
Preventive healthcare focuses on preventing health problems from occurring and also focuses on diagnosing problems before any symptoms or complications are developed. Vaccination plays a crucial role in preventive healthcare as it can build a person’s immunity for the viral infections before the person is exposed to the virus. In case of preventive healthcare, the vaccines developed are generally made up of viral antigens so that the immune system detect them. Thus, increasing awareness about preventive healthcare through vaccination is fueling the growth of the viral antigens market.
Viral Antigens Market Report Segmentation Analysis
Key segments that contributed to the derivation of the Viral Antigens Market analysis are component, technique, and end user.
- Based on component, the Viral Antigens Market is segmented into Influenza Viral Antigens, Coronavirus Antigens, Zika Virus Antigens, Ebola Virus Antigens, Dengue Virus Antigens, Herpes Simplex Virus (HSV) Viral Antigens, Rotavirus Viral Antigens, Hepatitis A-E Virus Antigens, Measles Virus Antigens, Mumps/Parotitis Virus Antigens, and others. The influenza viral antigens segment held the largest market share in 2023. Around 2,000 influenza viruses are antigenically characterized by the CDC each year to compare how similar currently circulating influenza viruses are to those used in the influenza vaccine and to detect changes in circulating influenza viruses. Antigenic characterization may imply the capacity of the flu vaccine to induce an immune response against influenza viruses that circulate in humans.
- By technique, the market is segmented into ELISA, Immunoassay, Hemagglutination, Radioimmunoassay (RIA), Immunoperoxidase Staining, Immunofluorescence, and Others. The ELISA segment held the largest share of the market in 2023.
- In terms of end user, the market is segmented into Hospitals, Clinics, Laboratories, Diagnostic Centers, Blood Banks, and Research Institutes. The diagnostic segment dominated the market in 2023.
Viral Antigens Market Share Analysis by Geography
The geographic scope of the Viral Antigens Market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South America/South & Central America.
North America has dominated the Viral Antigens Market. In North America, the US holds the significant share of the multiple sclerosis therapeutics market. The growth of the market in the country is primarily driven by vast number of R&D activities for development of vaccination, financial aids by governments, other private, and non-private organizations for vaccination druves, and increasing prevalence of viral infections in the country. Additionally, increasing awareness regarding the preventive healthcare is expected to boost the adoption and acceptance of the products during the forecast period.
Viral Antigens Market Report Scope
Viral Antigens Market News and Recent Developments
The Viral Antigens Market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for viral antigens and strategies:
- Sino Biological Inc launched the world largest recombinant viral antigen collection, ProVir. The product line features a wide range of high quality recombinant proteins expressed in insect and mammalian cells. These products are rigorously tested for their purity and bioactivity. This portfolio includes over 800 products from 45 different types, 350 strains of viruses. (Source: Sino Biological Inc, Company Website, 2020)
Viral Antigens Market Report Coverage and Deliverables
The “Viral Antigens Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Market dynamics such as drivers, restraints, and key opportunities
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Component Antigens ; Technique ; and End User ; and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, RoAPAC, RoE, RoMEA, RoSCAM, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For